Latest Breaking News On - Chronic limb threatening ischemia - Page 2 : comparemela.com

AI Measures Fat Around the Heart, a Key to Predicting Heart Attacks

A collaborative group of Cedars-Sinai investigators suggest artificial intelligence can accurately assess volume, density of heart fat-both of which are linked to cardiovascular risk

United statesNew zealandChristopher haigJ vasc endovascLewisb schwartzBreakthrough devices programUnited states food drug administrationFlexstep technologyEfemoral medicalUnited states foodDrug administrationEfemoral vascular scaffold systemBreakthrough deviceChronic limb threatening ischemia

GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. today announced that it has appointed Ms. Juliana Elstad to the Company s board of directors as an independent director, effective.

United statesJuliana elstadBoston scientificMedtronic incCompany governanceVibrato medicalChronic limb threatening ischemiaPeripheral arterialImpleo medicalElstad medicalIntelect medicalTranscranial magnetic stimulationMajor depressive disorder

GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

/PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company s.

United statesJuliana elstadBoston scientificMedtronic incCompany governanceVibrato medicalChronic limb threatening ischemiaPeripheral arterialImpleo medicalElstad medicalIntelect medicalTranscranial magnetic stimulationMajor depressive disorder

BioGenCell launches US clinical trial operations at University of Maryland

BioGenCell launches US clinical trial operations at University of Maryland
thedailyrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailyrecord.com Daily Mail and Mail on Sunday newspapers.

United statesUniversity of marylandLaniado hospitalChronic limb threatening ischemia

Inari PADs cardiovascular holdings with $415M Limflow acquisition

Just weeks after securing U.S. FDA approval for its flagship system to treat chronic limb-threatening ischemia (CLTI), Limflow SA kept the good news flowing to investors with the announcement of an agreement to be acquired by Inari Medical Inc. in a deal valued at up to $415 million. Inari will pay $250 million in cash at closing with up to $165 million in additional payments going to Limflow based on achievement of specified commercial and reimbursement milestones starting in 2025. The companies expect the deal to close by the end of the year.

Inari medical incInari medicalInari medical incLimflow saChronic limb threatening ischemiaDeep vein thrombosisTranscatheter arterialization